[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 116, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1635958, "exercisedValue": 0, "unexercisedValue": 3699450}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 943077, "exercisedValue": 0, "unexercisedValue": 1056212}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 45, "title": "General Counsel & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 816300, "exercisedValue": 0, "unexercisedValue": 860184}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 42.05, "open": 41.88, "dayLow": 40.93, "dayHigh": 43.88, "regularMarketPreviousClose": 42.05, "regularMarketOpen": 41.88, "regularMarketDayLow": 40.93, "regularMarketDayHigh": 43.88, "payoutRatio": 0.0, "beta": 2.621, "forwardPE": -4.0146656, "volume": 74084, "regularMarketVolume": 74084, "averageVolume": 387468, "averageVolume10days": 274180, "averageDailyVolume10Day": 274180, "bid": 31.16, "ask": 55.24, "bidSize": 1, "askSize": 2, "marketCap": 892162176, "fiftyTwoWeekLow": 26.7, "fiftyTwoWeekHigh": 91.83, "priceToSalesTrailing12Months": 109.84513, "fiftyDayAverage": 39.6749, "twoHundredDayAverage": 57.8128, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 529590688, "profitMargins": 0.0, "floatShares": 15702041, "sharesOutstanding": 20369000, "sharesShort": 1742912, "sharesShortPriorMonth": 1880004, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0856, "heldPercentInsiders": 0.00161, "heldPercentInstitutions": 1.22016, "shortRatio": 5.78, "shortPercentOfFloat": 0.0857, "impliedSharesOutstanding": 20861600, "bookValue": 21.592, "priceToBook": 2.0285292, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -212562000, "trailingEps": -10.66, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 65.204, "enterpriseToEbitda": -2.276, "52WeekChange": 0.07079196, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 43.8, "targetHighPrice": 270.0, "targetLowPrice": 28.0, "targetMeanPrice": 97.66667, "targetMedianPrice": 82.5, "recommendationKey": "none", "numberOfAnalystOpinions": 12, "totalCash": 327991008, "totalCashPerShare": 16.102, "ebitda": -232714000, "totalDebt": 1066000, "quickRatio": 8.299, "currentRatio": 8.44, "totalRevenue": 8122000, "debtToEquity": 0.243, "revenuePerShare": 0.412, "returnOnAssets": -0.39945, "returnOnEquity": -0.63556, "grossProfits": -178112992, "freeCashflow": -90041376, "operatingCashflow": -163910000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -28.68838, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "regularMarketChange": 1.75, "regularMarketDayRange": "40.93 - 43.88", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 387468, "fiftyTwoWeekLowChange": 17.099998, "fiftyTwoWeekLowChangePercent": 0.64044935, "fiftyTwoWeekRange": "26.7 - 91.83", "fiftyTwoWeekHighChange": -48.030003, "fiftyTwoWeekHighChangePercent": -0.5230317, "fiftyTwoWeekChangePercent": 7.079196, "earningsTimestamp": 1746189000, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1755261000, "earningsCallTimestampStart": 1730898000, "earningsCallTimestampEnd": 1730898000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.66, "epsForward": -10.91, "epsCurrentYear": -12.99914, "priceEpsCurrentYear": -3.3694537, "fiftyDayAverageChange": 4.125099, "fiftyDayAverageChangePercent": 0.10397252, "twoHundredDayAverageChange": -14.012802, "regularMarketChangePercent": 4.161712, "regularMarketPrice": 43.8, "marketState": "REGULAR", "longName": "Praxis Precision Medicines, Inc.", "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1751391933, "shortName": "Praxis Precision Medicines, Inc", "twoHundredDayAverageChangePercent": -0.24238235, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "cryptoTradeable": false, "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]